Global Growth Lead - Advanced Therapies

TTP; Cambridge; On-site; GBP 85,000 - 120,000; Full time

Benefits offered by this job

Profit-related bonus

25 days holiday

Private medical insurance for staff

Life insurance

Electric car leasing

Cycle to work

Season ticket loan

Job summary

TTP is a leading independent technology and product development consultancy with a long history of helping clients solve complex challenges. The Advanced Therapies team focuses on enabling cell and gene therapy developers to scale manufacturing, improve cost efficiency and throughput.

We are seeking a Global Business Development Lead who will own the BD plan, identify opportunities, and drive strategic relationships with senior decision-makers across the global therapies market.

Qualifications

• Minimum 2.1 degree in a relevant scientific or engineering discipline.
• In-depth knowledge of Advanced Therapies manufacturing processes, equipment, pharmaceutical process development, and GMP qualification.
• Proven track record of winning technical programmes and opening new markets.
• Willingness to travel extensively, internationally.

Responsibilities

• Own the business development plan for developing commercial relationships with senior decision-makers across the global therapies market.
• Build and maintain relationships with newly identified prospects and existing clients.
• Develop targeted campaigns, materials and market insights to support BD efforts.

Skills

Business development

Strategic thinking

Relationship building

Lead generation

Education

2.1 degree in science/engineering

Job description

TTP is a leading independent technology and product development consultancy with a long history of helping clients solve complex challenges. The Advanced Therapies team focuses on enabling cell and gene therapy developers to scale manufacturing, improve cost efficiency and throughput.

We are seeking a Global Business Development Lead who will own the BD plan, identify opportunities, and drive strategic relationships with senior decision-makers across the global therapies market.